Delivery Order SPE2DB22D3016-SPE2DB25FBHZ4
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,091.21 delivery order on September 8, 2025, for ADDYI (flibanserin) 100 mg tablets in quantities of 30s. This is a firm fixed-price, non-set-aside contract with a completion date of September 9, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of ADDYI 100 mg tablets in quantities of 30 tablets per unit, with a ceiling value of $31,068.83. This competitive award utilizes firm fixed pricing and is structured as a delivery order without set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of ADDYI (flibanserin) 100 mg tablets in quantities of 30 tablets, with a contract ceiling value of $2,903.61. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $5,184.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADDYI (flibanserina) 100 mg tablets in quantities of 30 units. This delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (flibanserin) on August 21, 2025, with a ceiling value of $7,861.63 and an ultimate completion date of August 22, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $13.5K to AmerisourceBergen Drug Corp for the supply of ADDYI (flibanseramine) 100 mg tablets in a 30-count package on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price terms and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (flibanserin) in a quantity of 30 units, valued at $5,525.08. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location in the same city. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,935.74 to AmerisourceBergen Drug Corp for ADDYI (flibanserin) 100 mg tablets in quantities of 30 on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The product...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,102.82 to AmerisourceBergen Drug Corp for ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This firm fixed price, non-set-aside delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of ADDYI 100 mg tablets (30-count unit dose packaging) with a contract ceiling value of $6,180.54 and an ultimate completion date of August 4, 2025. This delivery order represents a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBHZ4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of ADDYI (flibanserrin) 100 mg tablets in quantities of 30 units. This competitive award, issued with no set-aside designation, carries a ceiling value of $5,740.71 and is priced on a firm fixed-price basis, with an ultimate completion date of September 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this delivery order from its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The parent IDC represents the company's strategic role in providing critical medical commodities, including specialty medications, vaccines, and other healthcare supplies, to the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 9/11/25 |